// App-Quantinova.ai

P2-05-08 : p53 deficiency enhances metastatic potential of triple negative breast cancer by promoting growth in primary and metastatic sites

Researchers

Presenter

  • Powell E

Principal Investigators

  • Shao J

  • Mistry N

  • Piwnica-Worms D

  • Piwnica-Worms H

  • Yuan Y

  • Tieu T

  • Decker K

  • Chen H-C

  • Cai S

  • Do K-A

  • Heffernan TP

  • Edwards J

Medical Centers

  • Washington University School of Medicine, St. Louis, MO

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved